• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

(18)F-FDG PET/CT在卵巢恶性肿瘤检测中的价值

Value of (18)F-FDG PET/CT in the Detection of Ovarian Malignancy.

作者信息

Park Taegyu, Lee Sinae, Park Soyeon, Lee Eunsub, Pahk Kisoo, Rhee Seunghong, Cho Jaehyuk, Kim Chulhan, Eo Jae Seon, Choe Jae Gol, Kim Sungeun

机构信息

Department of Nuclear Medicine, Korea University Guro Hospital, Seoul, South Korea.

Department of Nuclear Medicine, Korea University Anam Hospital, #73, Inchon-ro, Seoungbuk-gu, Seoul, 136-705 South Korea.

出版信息

Nucl Med Mol Imaging. 2015 Mar;49(1):42-51. doi: 10.1007/s13139-014-0303-3. Epub 2014 Oct 28.

DOI:10.1007/s13139-014-0303-3
PMID:25774237
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4354788/
Abstract

PURPOSE

Ovarian cancer is a leading cause of gynecologic malignancy. As symptoms of ovarian cancer are nonspecific, only 20 % of ovarian cancers are diagnosed while they are still limited to the ovaries. Thus, early and accurate detection of disease is important for an improved prognosis. For the accurate and effective diagnosis of ovarian malignancy on (18)F-fluorodeoxyglucose ((18)F-FDG) positron emission tomography/computed tomography (PET/CT), we analyzed several parameters, including visual assessment.

METHOD

A total of 51 peritoneal lesions in 19 patients who showed ovarian masses with diffuse peritoneal infiltration were enrolled. Twelve patients were confirmed to have ovarian malignancy and seven patients with benign disease by pathologic examination. All patients were examined by (18)F-FDG PET/CT, and an additional 2-h delayed (18)F-FDG PET/CT was also performed for 15 patients with 42 peritoneal lesions. We measured semiquantitative parameters including maximum and mean standardized uptake values (SUVmax, SUVmean), metabolic tumor volume (MTV), and total lesion glycolysis (TLG) on a 1-h initial (18)F-FDG PET/CT image (Parameter1) and on a 2-h delayed image (Parameter2). Additionally, retention indices of each parameter were calculated, and each parameter among the malignant and benign lesions was compared by Mann-Whitney U test. We also assessed the visual characteristics of each peritoneal lesion, including metabolic extent, intensity, shape, heterogeneity, and total visual score. Associations between visual grades and malignancy were analyzed using linear by linear association methods. Moreover, a receiver operating characteristic (ROC) curve was analyzed to compare the effectiveness of significant parameters.

RESULT

In a comparison between the malignant and benign groups in the analysis of 51 total peritoneal lesions, SUVmax1, SUVmean1, and TLG1 showed significant differences. Also, in the analysis of 42 peritoneal lesions that underwent an additional 2-h (18)F-FDG PET/CT examination, SUVmax1,2, SUVmean1,2, TLG2, and the RI of TLG showed significant differences between the malignant and benign groups. MTV did not show significant differences in either the analysis of 51 peritoneal lesions or of 42 lesions. Regarding visual assessments, metabolic intensity, shape, heterogeneity, and total visual score showed an association with malignancy. In the ROC analysis, the AUC of the visual score was larger than the AUC of other parameters in both the analyses of 51 peritoneal lesions and of 42 lesions.

CONCLUSION

Although further study with a larger patient population is needed, the visual assessment of (18)F-FDG PET/CT imaging has a primary role in the detection of malignancy in ovarian cancer patients with assistance from other semi-quantitative parameters.

摘要

目的

卵巢癌是妇科恶性肿瘤的主要病因。由于卵巢癌症状不具特异性,只有20%的卵巢癌在仍局限于卵巢时被诊断出来。因此,早期准确检测疾病对于改善预后很重要。为了在氟代脱氧葡萄糖(18F-FDG)正电子发射断层扫描/计算机断层扫描(PET/CT)上准确有效地诊断卵巢恶性肿瘤,我们分析了包括视觉评估在内的几个参数。

方法

纳入19例显示卵巢肿块伴弥漫性腹膜浸润患者的51个腹膜病变。经病理检查,12例患者确诊为卵巢恶性肿瘤,7例为良性疾病。所有患者均接受18F-FDG PET/CT检查,另外15例有42个腹膜病变的患者还进行了2小时延迟18F-FDG PET/CT检查。我们在1小时初始18F-FDG PET/CT图像(参数1)和2小时延迟图像(参数2)上测量了半定量参数,包括最大和平均标准化摄取值(SUVmax、SUVmean)、代谢肿瘤体积(MTV)和总病变糖酵解(TLG)。此外,计算每个参数的保留指数,并通过Mann-Whitney U检验比较恶性和良性病变中的每个参数。我们还评估了每个腹膜病变的视觉特征,包括代谢范围、强度、形状、异质性和总视觉评分。使用线性关联方法分析视觉分级与恶性肿瘤之间的关联。此外,分析了受试者工作特征(ROC)曲线以比较重要参数的有效性。

结果

在对51个腹膜病变的分析中,恶性和良性组之间的比较显示,SUVmax1、SUVmean1和TLG1存在显著差异。同样,在对42个腹膜病变进行额外2小时18F-FDG PET/CT检查的分析中,SUVmax1,2、SUVmean1,2、TLG2和TLG的保留指数在恶性和良性组之间存在显著差异。MTV在对51个腹膜病变或42个病变的分析中均未显示出显著差异。关于视觉评估,代谢强度、形状、异质性和总视觉评分与恶性肿瘤相关。在ROC分析中,在对51个腹膜病变和42个病变的分析中,视觉评分的AUC均大于其他参数的AUC。

结论

尽管需要对更多患者进行进一步研究,但在其他半定量参数的辅助下,18F-FDG PET/CT成像的视觉评估在卵巢癌患者恶性肿瘤检测中起主要作用。

相似文献

1
Value of (18)F-FDG PET/CT in the Detection of Ovarian Malignancy.(18)F-FDG PET/CT在卵巢恶性肿瘤检测中的价值
Nucl Med Mol Imaging. 2015 Mar;49(1):42-51. doi: 10.1007/s13139-014-0303-3. Epub 2014 Oct 28.
2
Diagnostic ability of [F]FDG PET/CT for distinguishing benign from malignant spleen lesions.[F]氟代脱氧葡萄糖正电子发射断层扫描/计算机断层扫描([F]FDG PET/CT)鉴别脾脏良恶性病变的诊断能力。
Eur Radiol. 2025 Jan;35(1):479-486. doi: 10.1007/s00330-024-10961-8. Epub 2024 Jul 18.
3
The clinical value of texture analysis of dual-time-point F-FDG-PET/CT imaging to differentiate between F-FDG-avid benign and malignant pulmonary lesions.双时相 F-FDG-PET/CT 纹理分析在鉴别 F-FDG 摄取的肺良恶性病变中的临床价值。
Eur Radiol. 2020 Mar;30(3):1759-1769. doi: 10.1007/s00330-019-06463-7. Epub 2019 Nov 14.
4
Characterization of focal hypermetabolic thyroid incidentaloma: An analysis with F-18 fluorodeoxyglucose positron emission tomography/computed tomography parameters.局灶性甲状腺代谢亢进偶发瘤的特征:一项使用F-18氟脱氧葡萄糖正电子发射断层扫描/计算机断层扫描参数的分析。
World J Clin Cases. 2022 Jan 7;10(1):155-165. doi: 10.12998/wjcc.v10.i1.155.
5
Diagnostic importance of 18F-FDG PET/CT parameters and total lesion glycolysis in differentiating between benign and malignant adrenal lesions.18F-FDG PET/CT参数及总病变糖酵解在鉴别肾上腺良恶性病变中的诊断价值
Nucl Med Commun. 2017 Sep;38(9):788-794. doi: 10.1097/MNM.0000000000000712.
6
Differentiation of soft tissue and bone sarcomas from benign lesions utilizing F-FDG PET/CT-derived parameters.利用 F-FDG PET/CT 衍生参数区分软组织和骨肉瘤与良性病变。
BMC Med Imaging. 2020 Jul 25;20(1):85. doi: 10.1186/s12880-020-00486-z.
7
Assessment of Mediastinal Tumors Using SUV and Volumetric Parameters on FDG-PET/CT.利用 FDG-PET/CT 上的 SUV 和体积参数评估纵隔肿瘤
Asia Ocean J Nucl Med Biol. 2017 Winter;5(1):22-29. doi: 10.22038/aojnmb.2016.7996.
8
Multiple metabolic parameters and visual assessment of F-FDG uptake heterogeneity of PET/CT in advanced gastric cancer and primary gastric lymphoma.多代谢参数和 F-FDG 摄取异质性的 PET/CT 视觉评估在晚期胃癌和原发性胃淋巴瘤中的应用。
Abdom Radiol (NY). 2020 Nov;45(11):3569-3580. doi: 10.1007/s00261-020-02503-9.
9
Diagnostic value of F-FDG PET/CT and MRI for intraspinal lesions: A comparative study.F-FDG PET/CT与MRI对脊柱内病变的诊断价值:一项对比研究。
Med Int (Lond). 2021 Nov 30;1(5):23. doi: 10.3892/mi.2021.23. eCollection 2021 Nov-Dec.
10
Diagnostic Value of Volume-Based Fluorine-18-Fluorodeoxyglucose PET/CT Parameters for Characterizing Thyroid Incidentaloma.基于氟-18-氟代脱氧葡萄糖 PET/CT 参数对甲状腺偶发瘤进行特征分析的诊断价值。
Korean J Radiol. 2018 Mar-Apr;19(2):342-351. doi: 10.3348/kjr.2018.19.2.342. Epub 2018 Feb 22.

引用本文的文献

1
Feasibility of F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography for the Assessment of Canine Granulosa Cell Tumours in Two Dogs.F-氟代脱氧葡萄糖正电子发射断层扫描/计算机断层扫描评估两例犬颗粒细胞瘤的可行性。
Vet Med Sci. 2025 Jan;11(1):e70126. doi: 10.1002/vms3.70126.
2
A Review of Nuclear Medicine Approaches in the Diagnosis and the Treatment of Gynecological Malignancies.核医学方法在妇科恶性肿瘤诊断与治疗中的综述
Cancers (Basel). 2022 Mar 31;14(7):1779. doi: 10.3390/cancers14071779.
3
Repurposing C-PS13 for PET Imaging of Cyclooxygenase-1 in Ovarian Cancer Xenograft Mouse Models.将 C-PS13 再用于卵巢癌异种移植小鼠模型中环氧化酶-1 的 PET 成像。
J Nucl Med. 2021 May 10;62(5):665-668. doi: 10.2967/jnumed.120.249367. Epub 2020 Sep 25.
4
Systematic Review on the Accuracy of Positron Emission Tomography/Computed Tomography and Positron Emission Tomography/Magnetic Resonance Imaging in the Management of Ovarian Cancer: Is Functional Information Really Needed?正电子发射断层扫描/计算机断层扫描与正电子发射断层扫描/磁共振成像在卵巢癌管理中的准确性系统评价:功能信息真的有必要吗?
World J Nucl Med. 2017 Jul-Sep;16(3):176-185. doi: 10.4103/wjnm.WJNM_31_17.
5
Quantitative single-photon emission computed tomography/computed tomography for technetium pertechnetate thyroid uptake measurement.用于高锝酸盐甲状腺摄取测量的定量单光子发射计算机断层扫描/计算机断层扫描
Medicine (Baltimore). 2016 Jul;95(27):e4170. doi: 10.1097/MD.0000000000004170.

本文引用的文献

1
The Clinical Role of Dual-Time-Point (18)F-FDG PET/CT in Differential Diagnosis of the Thyroid Incidentaloma.双时相(18)F-FDG PET/CT在甲状腺偶发瘤鉴别诊断中的临床作用
Nucl Med Mol Imaging. 2014 Jun;48(2):121-9. doi: 10.1007/s13139-013-0247-z. Epub 2013 Dec 6.
2
Prognostic Significance of Volume-based Metabolic Parameters by (18)F-FDG PET/CT in Gallbladder Carcinoma.(18)F-FDG PET/CT基于体积的代谢参数在胆囊癌中的预后意义
Nucl Med Mol Imaging. 2012 Sep;46(3):201-6. doi: 10.1007/s13139-012-0147-7. Epub 2012 Jun 19.
3
The effectiveness of dual-phase 18F-FDG PET/CT in the detection of epithelial ovarian carcinoma: a pilot study.双相 18F-FDG PET/CT 在检测上皮性卵巢癌中的有效性:一项初步研究。
J Ovarian Res. 2014 Feb 5;7:15. doi: 10.1186/1757-2215-7-15.
4
Prognostic predictive value of total lesion glycolysis from 18F-FDG PET/CT in post-surgical patients with epithelial ovarian cancer.18F-FDG PET/CT 总病灶糖酵解对卵巢癌术后患者的预后预测价值。
Clin Nucl Med. 2013 Sep;38(9):715-20. doi: 10.1097/RLU.0b013e31829f57fa.
5
When should we recommend use of dual time-point and delayed time-point imaging techniques in FDG PET?何时应建议在 FDG PET 中使用双时相和延迟时相成像技术?
Eur J Nucl Med Mol Imaging. 2013 May;40(5):779-87. doi: 10.1007/s00259-013-2343-9. Epub 2013 Jan 30.
6
Dual-time-point FDG PET/CT for the evaluation of pediatric tumors.双时相氟代脱氧葡萄糖正电子发射断层扫描/计算机断层扫描在儿科肿瘤评估中的应用。
AJR Am J Roentgenol. 2013 Feb;200(2):408-13. doi: 10.2214/AJR.12.8930.
7
Preoperative [F]FDG PET/CT predicts recurrence in patients with epithelial ovarian cancer.术前 [F]FDG PET/CT 预测上皮性卵巢癌患者的复发。
J Gynecol Oncol. 2012 Jan;23(1):28-34. doi: 10.3802/jgo.2012.23.1.28. Epub 2012 Jan 9.
8
Prognostic value of metabolic tumor burden on 18F-FDG PET in nonsurgical patients with non-small cell lung cancer.代谢肿瘤负荷 18F-FDG PET 在非手术治疗的非小细胞肺癌患者中的预后价值。
Eur J Nucl Med Mol Imaging. 2012 Jan;39(1):27-38. doi: 10.1007/s00259-011-1934-6. Epub 2011 Sep 23.
9
Standard uptake value and metabolic tumor volume of ¹⁸F-FDG PET/CT predict short-term outcome early in the course of chemoradiotherapy in advanced non-small cell lung cancer.¹⁸F-FDG PET/CT 标准摄取值和代谢肿瘤体积可预测晚期非小细胞肺癌放化疗过程中早期的短期预后。
Eur J Nucl Med Mol Imaging. 2011 Sep;38(9):1628-35. doi: 10.1007/s00259-011-1838-5. Epub 2011 May 27.
10
Prognostic value of 18F-FDG PET image-based parameters in oesophageal cancer and impact of tumour delineation methodology.基于 18F-FDG PET 图像参数对食管癌的预后价值及肿瘤勾画方法的影响。
Eur J Nucl Med Mol Imaging. 2011 Jul;38(7):1191-202. doi: 10.1007/s00259-011-1755-7. Epub 2011 Mar 2.